New pill aims to boost weight loss and fight inflammation in obesity and diabetes

NCT ID NCT07055516

Ongoing Disease control Sponsor: NodThera Limited Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 25 times

Summary

This study tests an experimental drug called NT-0796 in 176 adults with obesity, some of whom also have type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps reduce inflammation and body weight more than diet and exercise alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Investigative Site

Hialeah, Florida, 33016, United States
Investigative Site

Jacksonville, Florida, 32216, United States
Investigative Site

Miami, Florida, 33147, United States
Investigative Site

Port Orange, Florida, 32127, United States
Investigative Site

Columbus, Ohio, 43213, United States
Investigative Site

Dallas, Texas, 75230, United States
Investigative Site

Manassas, Virginia, 20110, United States
Investigative Sites

Marrero, Louisiana, 70006, United States
Investigative site

Mesa, Arizona, 85225, United States
Investigative site

Los Angeles, California, 90057, United States
Investigative site

Cooper City, Florida, 33024, United States

Conditions

Explore the condition pages connected to this study.

OBESITY AND TYPE 2 DIABETES